eloralintide vs retatrutide Eloralintide, a selective amylin receptor agonist for the treatment of obesity: a 48-week phase 2, multicentre, double-blind, randomised, placebo-controlled trial Comparing Eloralintide and Retatrutide for

It matches the A1c reduction of tirzepatide but contains renal and lipid benefits that tirzepatide cannot match

Much like Mounjaro, Wegovy works by mimicking the natural hormone GLP-1 to reduce appetite and slow down digestion

Novo Nordisk, the manufacturer of Wegovy, sponsors NovoCare, a website with resources that help people check insurance coverage, manage the cost of medication, explore savings and assistance options, and more

How GLP-1 Medications Work With Lifestyle Habits GLP-1 medications support the biological systems involved in appetite, digestion, and metabolic health, but steady progress depends on daily habits that reinforce the benefits of your prescription